Low expression of ZMYND8 correlates with aggressive features and poor prognosis in nasopharyngeal carcinoma

References

• Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol. 1994;21:382–397.8209270
   PubMed Web of Science ®Google Scholar
• Lee AW, Ng WT, Chan YH, Sze H, Chan C, Lam TH. The battle against nasopharyngeal cancer. Radiother Oncol. 2012;104:272–278. doi:10.1016/j.radonc.2012.08.00122938727
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, Reddy MS. Nasopharyngeal carcinoma. Curr Treat Options Oncol. 2002;3:21–32.12057084
   PubMedGoogle Scholar
• Endo K, Kondo S, Shackleford J, et al. Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene. 2009;28:1725–1735. doi:10.1038/onc.2009.2019234486
   PubMed Web of Science ®Google Scholar
• Fossey SC, Kuroda S, Price JA, Pendleton JK, Freedman BI, Bowden DW. Identification and characterization of PRKCBP1, a candidate RACK-like protein. Mamm Genome. 2000;11:919–925. doi:10.1007/s00335001017411003709
   PubMed Web of Science ®Google Scholar
• Ansieau S, Sergeant A. [BS69 and RACK7, a potential novel class of tumor suppressor genes]. Pathologie-biologie. 2003;51:397–399.12948759
   PubMedGoogle Scholar
• Gong F, Miller KM. Double duty: ZMYND8 in the DNA damage response and cancer. Cell Cycle. 2018;17:414–420. doi:10.1080/15384101.2017.137615029393731
   PubMed Web of Science ®Google Scholar
• Shen H, Xu W, Guo R, et al. Suppression of enhancer overactivation by a RACK7-histone demethylase complex. Cell. 2016;165:331–342. doi:10.1016/j.cell.2016.02.06427058665
   PubMed Web of Science ®Google Scholar
• Li N, Li Y, Lv J, et al. ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes. Mol Cell. 2016;63:470–484. doi:10.1016/j.molcel.2016.06.03527477906
   PubMed Web of Science ®Google Scholar
• Spruijt CG, Luijsterburg MS, Menafra R, et al. ZMYND8 Co-localizes with NuRD on target genes and regulates poly(ADP-Ribose)-dependent recruitment of GATAD2A/NuRD to sites of DNA damage. Cell Rep. 2016;17:783–798. doi:10.1016/j.celrep.2016.09.03727732854
   PubMed Web of Science ®Google Scholar
• Delgado-Benito V, Rosen DB, Wang Q, et al. The chromatin reader ZMYND8 regulates Igh enhancers to promote immunoglobulin class switch recombination. Mol Cell. 2018;72:636–649 e638. doi:10.1016/j.molcel.2018.08.04230293785
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615. doi:10.1038/nature1016621720365
   PubMed Web of Science ®Google Scholar
• Park J, Betel D, Gryfe R, et al. Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites. Cancer Res. 2002;62:1284–1288.11888892
   PubMed Web of Science ®Google Scholar
• Basu M, Khan MW, Chakrabarti P, Das C. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation. Biochim Biophys Acta Gene Regul Mech. 2017;1860:450–459. doi:10.1016/j.bbagrm.2017.02.00428232094
   PubMed Web of Science ®Google Scholar
• Cai MY, Zhang B, He WP, et al. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci. 2010;101:1543–1549. doi:10.1111/j.1349-7006.2010.01560.x20367640
   PubMed Web of Science ®Google Scholar
• Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000;45:23–41.10802332
   PubMed Web of Science ®Google Scholar
• Luo RZ, Cai PQ, Li M, et al. Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma. PLoS One. 2014;9:e85592. doi:10.1371/journal.pone.008559224475046
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16:1310–1317. doi:10.1200/JCO.1998.16.4.13109552031
   PubMed Web of Science ®Google Scholar
• Guo X, Zeng Y, Deng H, et al. Genetic polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the risk of nasopharyngeal carcinoma in a Han Chinese population of Southern China. BMC Res Notes. 2010;3:212. doi:10.1186/1756-0500-3-21220663217
   PubMedGoogle Scholar
• Luo DH, Chen QY, Liu H, et al. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways. J Transl Med. 2013;11:203. doi:10.1186/1479-5876-11-20323987636
   PubMed Web of Science ®Google Scholar
• Antal CE, Hudson AM, Kang E, et al. Cancer-associated protein kinase C mutations reveal kinase’s role as tumor suppressor. Cell. 2015;160:489–502. doi:10.1016/j.cell.2015.01.00125619690
   PubMed Web of Science ®Google Scholar
• Gong F, Chiu LY, Cox B, et al. Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. Genes Dev. 2015;29:197–211. doi:10.1101/gad.252189.11425593309
   PubMed Web of Science ®Google Scholar
• Adhikary S, Sanyal S, Basu M, et al. Selective recognition of H3.1K36 dimethylation/H4K16 acetylation facilitates the regulation of All-trans-retinoic Acid (ATRA)-responsive genes by putative chromatin reader ZMYND8. J Biol Chem. 2016;291:2664–2681. doi:10.1074/jbc.M115.67998526655721
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Y, Luo W. ZMYND8 is a primary HIF coactivator that mediates breast cancer progression. Mol Cell Oncol. 2018;5:e1479619. doi:10.1080/23723556.2018.147961930250924
   PubMed Web of Science ®Google Scholar
• Panagopoulos I, Micci F, Thorsen J, et al. Fusion of ZMYND8 and RELA genes in acute erythroid leukemia. PLoS One. 2013;8:e63663. doi:10.1371/journal.pone.006366323667654
   PubMed Web of Science ®Google Scholar